These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 23342872

  • 1. [Management of hyperglycaemia in type 2 diabetes: a patient-centered approach].
    Scheen AJ, Mathieu C.
    Rev Med Liege; 2012 Dec; 67(12):623-31. PubMed ID: 23342872
    [Abstract] [Full Text] [Related]

  • 2. Patient-Centered Guidelines for Geriatric Diabetes Care: Potential Missed Opportunities to Avoid Harm.
    McCreedy EM, Kane RL, Gollust SE, Shippee ND, Clark KD.
    J Am Board Fam Med; 2018 Dec; 31(2):192-200. PubMed ID: 29535235
    [Abstract] [Full Text] [Related]

  • 3. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH, Livingston M, Malipatil N, Becher M, Craig J, Stedman M, Fryer AA.
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: A retrospective analysis of primary care data, 2010-2017.
    Dennis JM, Henley WE, McGovern AP, Farmer AJ, Sattar N, Holman RR, Pearson ER, Hattersley AT, Shields BM, Jones AG, MASTERMIND consortium.
    Diabetes Obes Metab; 2019 Jul; 21(7):1576-1584. PubMed ID: 30828962
    [Abstract] [Full Text] [Related]

  • 7. [Management of type 2 diabetes: new or previous agents, how to choose?].
    Halimi S.
    Presse Med; 2013 May; 42(5):861-70. PubMed ID: 23643613
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of English general practice level data linking medication levels, service activity and demography to levels of glycaemic control being achieved in type 2 diabetes to improve clinical practice and patient outcomes.
    Heald A, Davies M, Stedman M, Livingston M, Lunt M, Fryer A, Gadsby R.
    BMJ Open; 2019 Sep 06; 9(9):e028278. PubMed ID: 31494602
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults.
    Tasci I, Safer U, Naharci I, Sonmez A.
    Prim Care Diabetes; 2018 Apr 06; 12(2):192-194. PubMed ID: 29396204
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Management of the patient with advanced complications, functional decline, and persistent hyperglycemia.
    Zettervall DK.
    Consult Pharm; 2010 Jun 06; 25 Suppl B():5-10. PubMed ID: 20726377
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.
    Khunti K, Gomes MB, Pocock S, Shestakova MV, Pintat S, Fenici P, Hammar N, Medina J.
    Diabetes Obes Metab; 2018 Feb 06; 20(2):427-437. PubMed ID: 28834075
    [Abstract] [Full Text] [Related]

  • 17. Optimal glycaemic control in elderly people with type 2 diabetes: what does the evidence say?
    Mathur S, Zammitt NN, Frier BM.
    Drug Saf; 2015 Jan 06; 38(1):17-32. PubMed ID: 25481812
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.